Laredo Petroleum, Inc. (NYSE:LPI) shares moved up 5.76% in last trading session and ended the day at $13.04. LPI Gross Margin is 59.50% and its has a return on assets of -2.90%. Laredo Petroleum, Inc. (NYSE:LPI) quarterly performance is 67.39%.
Laredo Petroleum, Inc. (NYSE:LPI) said that, it will host a conference call on Thursday, November 5, 2015 at 7:30 a.m. CT (8:30 a.m. ET) to discuss its third-quarter 2015 financial and operating results. Laredo plans to release earnings the same day before market open.
Lithia Motors Inc. (NYSE:LAD) ended the last trading day at $118.33. Company weekly volatility is calculated as 3.62% and price to cash ratio as 132.99. Lithia Motors Inc. (NYSE:LAD) showed a weekly performance of 4.59%.
Lithia Motors Inc. (NYSE:LAD) announced a cash dividend payment of $0.2 per share is scheduled to be paid on November 20, 2015. Shareholders who purchased LAD prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 3rd quarter that LAD has paid the same dividend. At the current stock price of $117.44, the dividend yield is .68%.
On 03 November, Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) shares moved up 2.47% and was closed at $70.96. Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) year to date (YTD) performance is 357.81%.
Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) said that, it will release its 2015 third quarter financial results on Wednesday, November 11, 2015, before the market opens.
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) shares decreased -23.20% in last trading session and ended the day at $31.61. AMAG Gross Margin is 81.00% and its has a return on assets of 15.00%. AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) quarterly performance is -54.43%.
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) reported unaudited consolidated financial results for the third quarter and year-to-date periods ended September 30, 2015. Total revenues for the third quarter of 2015 increased to $96.2 million, compared with $25.5 million in the third quarter of 2014. This increase is primarily related to the additions of Makena® (hydroxyprogesterone caproate injection) in November 2014 and Cord Blood Registry (CBR) in August 2015 to the company’s portfolio, which contributed revenue of $65.2 million and $7.2 million, respectively, to the third quarter 2015 results.
Groupon, Inc. (NASDAQ:GRPN) caters to the Technology space. It has a net profit margin of 2.60% and weekly performance is 17.49%. On the last day of trading company shares ended up at $4.03. Groupon, Inc. (NASDAQ:GRPN) distance from 50-day simple moving average (SMA50) is -8.86%.
Groupon, Inc. (NASDAQ:GRPN) reported a quarterly net loss of $27.6 million, or $0.04 per share, compared to a year-ago loss of $21.2 million, or $0.03 per share, in the year-ago period. Excluding items, the company’s adjusted earnings came in at $0.05 per share.
Leave a Reply